These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22205345)

  • 41. The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodies.
    Beyer K; Ariza A
    Curr Med Chem; 2008; 15(26):2748-59. PubMed ID: 18991634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.
    Gündner AL; Duran-Pacheco G; Zimmermann S; Ruf I; Moors T; Baumann K; Jagasia R; van de Berg WDJ; Kremer T
    Neurobiol Dis; 2019 Jan; 121():205-213. PubMed ID: 30236861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
    Quinn JG; Coulson DT; Brockbank S; Beyer N; Ravid R; Hellemans J; Irvine GB; Johnston JA
    Brain Res; 2012 Jun; 1459():71-80. PubMed ID: 22560502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson's disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings.
    Katayama T; Sawada J; Kikuchi-Takeguchi S; Kano K; Takahashi K; Saito T; Okizaki A; Hasebe N
    Neurosci Lett; 2020 Jan; 715():134564. PubMed ID: 31733322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies.
    Yamamoto R; Iseki E; Marui W; Togo T; Katsuse O; Kato M; Isojima D; Akatsu H; Kosaka K; Arai H
    Neuropathology; 2005 Sep; 25(3):188-94. PubMed ID: 16193834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early-onset dementia with Lewy bodies.
    Takao M; Ghetti B; Yoshida H; Piccardo P; Narain Y; Murrell JR; Vidal R; Glazier BS; Jakes R; Tsutsui M; Spillantini MG; Crowther RA; Goedert M; Koto A
    Brain Pathol; 2004 Apr; 14(2):137-47. PubMed ID: 15193026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Formation and development of Lewy pathology: a critical update.
    Jellinger KA
    J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.
    Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K
    J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.
    Fathy YY; Jonker AJ; Oudejans E; de Jong FJJ; van Dam AW; Rozemuller AJM; van de Berg WDJ
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):262-277. PubMed ID: 29797340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
    Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG
    Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC.
    Sano K; Atarashi R; Satoh K; Ishibashi D; Nakagaki T; Iwasaki Y; Yoshida M; Murayama S; Mishima K; Nishida N
    Mol Neurobiol; 2018 May; 55(5):3916-3930. PubMed ID: 28550528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced lysosomal pathology caused by beta-synuclein mutants linked to dementia with Lewy bodies.
    Wei J; Fujita M; Nakai M; Waragai M; Watabe K; Akatsu H; Rockenstein E; Masliah E; Hashimoto M
    J Biol Chem; 2007 Sep; 282(39):28904-28914. PubMed ID: 17652097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.
    Smith BR; Nelson KM; Kemper LJ; Leinonen-Wright K; Petersen A; Keene CD; Ashe KH
    Acta Neuropathol Commun; 2019 Jul; 7(1):124. PubMed ID: 31362787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic review of gene expression studies in people with Lewy body dementia.
    Chowdhury A; Rajkumar AP
    Acta Neuropsychiatr; 2020 Dec; 32(6):281-292. PubMed ID: 32178745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
    Bougea A; Stefanis L; Emmanouilidou E; Vekrelis K; Kapaki E
    J Neural Transm (Vienna); 2020 Mar; 127(3):311-322. PubMed ID: 31912280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy.
    Mori F; Piao YS; Hayashi S; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
    J Neuropathol Exp Neurol; 2003 Aug; 62(8):812-9. PubMed ID: 14503637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topography of cortical thinning in the Lewy body diseases.
    Ye R; Touroutoglou A; Brickhouse M; Katz S; Growdon JH; Johnson KA; Dickerson BC; Gomperts SN
    Neuroimage Clin; 2020; 26():102196. PubMed ID: 32059167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.